May 28, 2026

Ōura’s wearables already track health metrics such as temperature, heart rate, and sleep, but the company is pushing further into health monitoring. It is working with the FDA on a study for a feature that could help identify early signs of hypertension. The IPO filing also comes as the company scales quickly: in October, Ōura said it had sold more than 5.5 million devices and expected 2025 revenue to exceed $1 billion

The Audit Enforcement and Risk Oversight program follows years of concerns over weak follow-through on HHS audits. Gustav Chiarello, HHS’s assistant secretary for financial resources, said states and grantees have faced little accountability despite audit reports flagging serious vulnerabilities and failures. The move also builds on CMS’s broader fraud crackdown, including a recent freeze on new Medicare enrollments for hospice and home health providers aimed at reducing fraud, waste, and abuse.

Hospitals owned by Mount Sinai, University of Michigan Health, and the University of Kansas filed lawsuits accusing CVS and its pharmacy subsidiaries of manipulating reimbursement rates for 340B drugs and keeping the difference as profit. The hospitals claim CVS identified claims as 340B-eligible only after insurers had already paid full rates, then reduced hospital reimbursement through affiliated PBM and pharmacy operations. The lawsuits add to broader scrutiny of PBMs and ongoing debates over transparency and reform in the drug pricing system.

ACAP raised concerns that CMS finalized the ACA marketplace rule much later than usual, forcing health plans to adjust their 2027 bid strategies under compressed timelines and incomplete information. The group also warned that expanded access to non-network and catastrophic plans may attract healthier members away from traditional Marketplace coverage, potentially harming market stability and exposing consumers to higher out-of-pocket costs and more complicated coverage decisions. The changes come as ACA exchanges are already dealing with premium increases and uncertainty tied to expiring post-pandemic subsidies.

These operational updates could streamline workflows and reduce administrative burden for both providers and payers navigating the dispute process. Since April 2022, more than 5 million disputes have entered the IDR system, far exceeding original expectations.